Poly saccharide-protein combination vaccine
A combined vaccine and polysaccharide technology, applied in the directions of viral antigen components, antibodies, and antibody medical components, can solve the problems of poor polysaccharide antigen reactivity, short-term immune response, low affinity, etc., to improve immune coverage, enhance immunogenicity, The effect of a good immune response
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
Embodiment 1
[0030] Example 1 A+C group meningococcal polysaccharide, Haemophilus influenzae type B polysaccharide-tetanus toxoid conjugate vaccine (1) Purification of polysaccharide
[0031] Suitable medium can be used for the production of polysaccharide vaccine. The liquid culture medium used for production should not contain components that can form a precipitate with the added cetyltrimethylammonium bromide. The culture medium should not contain harmful substances or other allergens.
[0032] After inoculating strains in a suitable medium, harvest after the logarithmic production period or before the stationary period. It is advisable to add formaldehyde solution to the culture for sterilization or heat sterilization to ensure the sterilization safety and not damage the polysaccharide of the bacteria. Centrifuge the sterilized single harvest (or combined harvest) to remove bacteria, collect the supernatant, add cetyltrimethylammonium bromide to it and mix it, and centrifuge to collect the...
Embodiment 3
[0048] Example 3 Groups A and C meningococcal polysaccharides, Haemophilus influenzae type B polysaccharides-mouse immunoglobulin (IgG) conjugate vaccine (1) Coupling of polysaccharides and mouse immunoglobulins (IgG) 1. Activated polysaccharides
[0049] Take A group (or C group) meningococcal (or Hib) polysaccharide 100mg (4mg / ml, 25ml), adjust the pH to 10.8 with 0.5M NaOH, add 50mg cyanogen bromide, and use 0.5M NaOH to maintain the pH at around 10.8±0.5 1 hour (22C). Then adjust the pH to 8.8 with 0.5M HCl, add 350mg adipic hydrazide (ADH), and react for 6 minutes; adjust the pH to 8.5 with 0.5M NaOH and maintain the pH within the range of 8.5±0.5 for 15 minutes; light at 4~8℃ Stir gently for 12 hours. Dialysis with pre-cooled 0.05M NaCl solution for 48 hours (4-8°C), during which time the fluid was changed 5 times (or ultrafiltration with a 100KD ultrafiltration membrane). The activated polysaccharide-ADH derivative was filtered with a 0.45μm filter membrane. 2. Coupling of ...
Embodiment 4
[0061] Example 4 Group A and C meningococcal polysaccharide, Haemophilus influenzae type B polysaccharide-human immunoglobulin (IgG) conjugate vaccine
[0062] The operation of this embodiment is the same as that of the third embodiment, except that the mouse serum immunoglobulin used in the third embodiment is replaced with human immunoglobulin for intravenous injection.
[0063] The conjugate vaccine prepared with human immunoglobulin as a carrier can be used for immunization of people of all age groups over 3 months old. The dosage range is 5-100μg / dose (calculated as polysaccharide), the number of immunizations is 2-3 times, and the immunization interval is 4-8 weeks.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com